KG-1a Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The KG-1a cell line is a subline derived from the original KG-1 cell line, which was established from the bone marrow of a patient diagnosed with acute myeloid leukemia (AML). KG-1a cells are classified as a human myeloid leukemia cell line and are particularly characterized by their immature, undifferentiated state. Unlike the parent KG-1 cells, which are primarily in the myeloblast stage, KG-1a cells exhibit a more primitive phenotype, resembling early myeloid progenitors or even stem cells. This makes them an invaluable tool for studying hematopoiesis, leukemia progression, and the molecular mechanisms underlying myeloid differentiation. KG-1a cells express various surface markers typical of early hematopoietic progenitors, such as CD34, CD38, and HLA-DR, while lacking markers associated with mature myeloid cells. This profile makes them highly suitable for research into stem cell biology and the development of leukemia therapies. Additionally, KG-1a cells are often used in drug screening assays to evaluate the efficacy of potential anti-leukemic compounds, particularly those targeting leukemic stem cells. Their ability to maintain an undifferentiated state in vitro also provides a robust model for gene expression studies and functional assays related to leukemia pathogenesis. As with other cell lines derived from human tissue, KG-1a cells are intended for research use only and are not suitable for therapeutic or in vivo applications. They require careful handling under sterile conditions, and their growth characteristics necessitate specific culture conditions, including the use of RPMI-1640 medium supplemented with fetal bovine serum. Researchers utilizing the KG-1a cell line can gain significant insights into the early stages of leukemic transformation and the role of hematopoietic progenitors in cancer biology. |
|---|---|
| Organism | Human |
| Tissue | Bone marrow |
| Disease | Acute myelogenous leukemia |
| Synonyms | KG-1A, KG1A, KG1a |
Characteristics
| Age | 59 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Cell type | Myeloblast |
| Growth properties | Suspension |
Regulatory Data
| Citation | KG-1a (Cytion catalog number 300234) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1824 |
Biomolecular Data
| Antigen expression | HLA A30, A31, B35, Cw4 |
|---|---|
| Isoenzymes | G6PD, B, PGM1, 1-2, PGM3, 0, ES-D, 1, Me-2, 1, AK-1, 0, GLO-1, 2 |
| Viruses | EBNA (EBNA ): negative |
| Reverse transcriptase | Negative |
Handling
| Culture Medium | IMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Doubling time | 45 hours |
| Subculturing | Transfer the cell suspension into sterile centrifuge tubes. Collect the cells by spinning down at 300xg for 3 minutes. Discard the supernatant and resuspend the pelleted cells in fresh cell culture medium. Adjust to an optimal cell density between 1 - 3 x 105 cells/ml. Split the cells when a maximum cell density of 1 - 2 x 106 cells/ml is reached. |
| Fluid renewal | Every 3 days |
| Post-Thaw Recovery | Allow the cells to recover from the freezing process for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300234-150724 | Certificate of Analysis | 23. May. 2025 | 300234 |